Helius Shares Positive PoNSTEP Study Results on PoNS Therapy for MS
NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) announced encouraging results from its PoNSTEP study, presented at the 2025 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting. The findings …
Helius Shares Positive PoNSTEP Study Results on PoNS Therapy for MS Read More